Allopurinol is a xanthine oxidase inhibitor indicated for gout, hyperuricemia during cancer therapy and recurrent calcium oxalate calculi. We supply it to US manufacturers of tablets and injection.
Data from PubChem (CID 135401907) and FDA’s substance registry
CAS number
315-30-0
Molecular formula
C5H4N4O
Molecular weight
136.1g/mol
FDA UNII
IUPAC name
1,5-dihydropyrazolo[5,4-d]pyrimidin-4-one
InChIKey
OFCNXPDARWKPPY-UHFFFAOYSA-N
- Appearance
- Fluffy white to off-white powder.
- Solubility
- Very slightly soluble in water and alcohol. Solubility in water at 37 °C is 80 mg/dL, and is greater in alkaline solution.
Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.
Worth settling with your inquiry
A long-established API with a short specification. Bulk density and flow are what usually differ between sources.
On the US market
- Reference product
- ZyloprimNDA 016084
- Approved ANDAs
- 12 with a marketed product
- Approved forms and strengths
- Tablet 100 mg, 200 mg, 300 mg
Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. The brand name belongs to its owner and identifies the reference product only.
Grade
USP or Ph. Eur. where a monograph exists, or your own specification.
Quantities
From development quantities for formulation work to commercial supply.
Packaging
To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.
Regulatory filings
US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.
Documents available with a quote
- Specification and certificate of analysis
- Safety data sheet
- Method of analysis
- DMF letter of authorization, where a US DMF is filed
- GMP certificate and inspection history of the site
- Residual solvents and elemental impurities statements
- Nitrosamine risk assessment
- TSE/BSE statement
Need something else for your QA file? Email info@yogpharma.com